BCG Vaccines Sales Market to Witness Exponential Growth by 2025

Press Release

The global BCG vaccines sales market was valued at $45 million in 2017, and is estimated to reach $65 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025.

BCG vaccine is a live attenuated vaccine used for the prevention of tuberculosis. It is administered to newborns from tuberculosis and leprosy prevalent regions. This vaccine is generally administered to children at birth in countries with high incidence of TB. However, in low incidence regions, only children at high risk are typically immunized, whereas adults are generally not immunized. However, adults (up to the age of 35) who are frequently exposed to drug-resistant TB may also be given BCG vaccine.

Get Report Sample Copy @

Major factors that drive the market growth are increase in the prevalence of tuberculosis and rise in technological advancements in vaccine research. Moreover, increase in government initiatives and focus on immunization programs globally boost the market growth. However, side-effects and a global shortage of BCG vaccine restrain the market growth. Furthermore, untapped market potential in developing regions is expected to provide lucrative opportunities for the market development.

This report segments the BCG vaccines sales market based on drug type, usage, end user, and region to provide a detailed assessment of the market. Based on drug type, it is bifurcated into immune BCG and therapy BCG. On the basis of usage, the market is categorized into tuberculosis and bladder cancer. Based on end user, it is segmented into adults and pediatrics. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Access Complete Research Report with TOC @


ü The study provides an in-depth analysis of the BCG vaccines sales market along with the current trends and future estimations to elucidate the imminent investment pockets.
ü A quantitative analysis from 2017 to 2025 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.
ü In-depth analysis of BCG vaccines sales based on drug type such as immune BCG and therapy BCG is carried out in the report.
ü The global BCG vaccines sales market scenario is comprehensively analyzed in accordance to the key cities.


By Drug Type
• Immune BCG
• Therapy BCG

By Usage
• Tuberculosis
• Bladder Cancer

By End User
• Pediatrics
• Adults

By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
o Latin America
o Middle East
o Africa

Request for Research Methodology @


  • AJ Vaccines
    • China National Pharmaceutical Group Corporation (Sinopharm)
    • Greensignal Bio Pharma Limited
    • Intervax Ltd
    • Japan BCG Laboratory
    • Merck & Company Inc
    • Sanofi S.A
    • Serum Institute of India Pvt. Ltd
    • Statens Serum Institute

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

  • Shanyao Group
    • Shanghai Institute of Biological Products
    • BCG Vaccine Laboratory India

About Us

Facto market insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.

Our in-house research experts have a wealth of knowledge in their respective domains. With Facto Market Research, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.

Contact Us

United States

150 State St.
Suite 301
Albany, NY 12207
United States
Email: [email protected]

Tel: +1 518-300-1215

This post was originally published on Industry Updates Daily

About the author

Jason lee